Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians. OBJECTIVE: To review the randomized controlled trials (RCTs) and systematic reviews related to the pharmacological management of NeP to develop a revised evidence‐based consensus statement on its management. METHODS: RCTs, systematic reviews and existing guidelines on the pharmacological management of NeP were evaluated at a consensus meeting in May 2012 and updated until September 2013. Medications were recommended in the consensus statement if their analgesic efficacy was supported by at least one methodologically sound RCT (class I or class II) showing significant benefit relative to placebo or another relevant control group. Recommendations for treatment were based on the degree of evidence of analgesic efficacy, safety and ease of use. RESULTS: Analgesic agents recommended for first‐line treatments are gabapentinoids (gabapentin and pregabalin), tricyclic antidepressants and serotonin noradrenaline reuptake inhibitors. Tramadol and controlled‐release opioid analgesics are recommended as second‐line treatments for moderate to severe pain. Cannabinoids are now recommended as third‐line treatments. Recommended fourth‐line treatments include methadone, anticonvulsants with lesser evidence of efficacy (eg, lamotrigine, lacos‐amide), tapentadol and botulinum toxin. There is support for some analgesic combinations in selected NeP conditions. CONCLUSIONS: These guidelines provide an updated, stepwise approach to the pharmacological management of NeP. Treatment should be individualized for each patient based on efficacy, side‐effect profile and drug accessibility, including cost. Additional studies are required to examine head‐to‐head comparisons among analgesics, combinations of analgesics, long‐term outcomes and treatment of pediatric, geriatric and central NeP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Results from both the scientific literature and public media revealed few references to nabilone abuse.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, nabilone theft did occur, although nabilone has no known street value.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“According to the literature, the positive side effects (euphoria, mood elevation) of nabilone, which may lead to abuse, generally occurred less frequently than the negative side effects (drowsiness, dizziness, and dry mouth).”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In the public media, patients described nabilone as not producing the same therapeutic and recreational effects as smoked cannabis.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Overall, the authors concluded that nabilone is rarely abused or diverted.”
From Nabilone for the Management of Pain (2016) · cites this paper as [32]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Bouhassira, D., Attal, N., Alchaar, H., Boureau, F., Brochet, B., Bruxelle, J., Cunin, G., Fermanian, J., Ginies, P., Grun-Overdyking, A., et al. (2005) · Pain · doi:10.1016/j.pain.2004.12.010 · Cited by 2,741
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Prevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., & Touboul, C. (2008) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,745
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy
Max, M. B., Lynch, S. A., Muir, J., Shoaf, S. E., Smoller, B., & Dubner, R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261904 · Cited by 1,117
The evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Smith, E. M. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R., Fadul, C. E., Knox, C., Le-Lindqwister, N., et al. (2013) · JAMA · doi:10.1001/jama.2013.2813 · Cited by 1,014
Torrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.11.008 · Cited by 1,000
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Treatment of neuropathic pain: an overview of recent guidelines.
O'Connor, A. B., & Dworkin, R. H. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.04.007 · Cited by 781
Bennett, M. I., Smith, B. H., Torrance, N., & Potter, J. (2005) · The Journal of Pain · doi:10.1016/j.jpain.2004.11.007 · Cited by 695
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000176753.45410.8b · Cited by 679
Bril, V., England, J., Franklin, G. M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D. J., Perkins, B., Russell, J. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166ebe · Cited by 634
Fishbain, D. A., Cole, B., Lewis, J., Rosomoff, H. L., & Rosomoff, R. S. (2008) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00370.x · Cited by 565
Topical capsaicin (high concentration) for chronic neuropathic pain in adults
Derry, S., Rice, A. S., Cole, P., Tan, T., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007393.pub4 · Cited by 559
Moulin, D., Clark, A., Gilron, I., Ware, M., Watson, C., Sessle, B., Coderre, T., Morley-Forster, P., Stinson, J., Boulanger, A., et al. (2007) · Pain Research and Management · doi:10.1155/2007/730785 · Cited by 557
Self-citationRowbotham, M. C., Goli, V., Kunz, N. R., & Lei, D. (2004) · Pain · doi:10.1016/j.pain.2004.05.010 · Cited by 521
Svendsen, K. B., Jensen, T. S., & Bach, F. W. (2004) · BMJ · doi:10.1136/bmj.38149.566979.ae · Cited by 500
Neuropathic pain following breast cancer surgery: proposed classification and research update
Jung, B. F., Ahrendt, G. M., Oaklander, A. L., & Dworkin, R. H. (2003) · Pain · doi:10.1016/s0304-3959(03)00241-0 · Cited by 476
Sindrup, S. H., Gram, L. F., Brøsen, K., Eshøj, O., & Mogensen, E. F. (1990) · Pain · doi:10.1016/0304-3959(90)91157-e · Cited by 463
Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy
Mao, J. (2002) · Pain · doi:10.1016/s0304-3959(02)00422-0 · Cited by 462
Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain
Ranoux, D., Attal, N., Morain, F., & Bouhassira, D. (2008) · Annals of Neurology · doi:10.1002/ana.21427 · Cited by 459
Interventional management of neuropathic pain: NeuPSIG recommendations
Dworkin, R. H., O’Connor, A. B., Kent, J., Mackey, S. C., Raja, S. N., Stacey, B. R., Levy, R. M., Backonja, M., Baron, R., Harke, H., et al. (2013) · Pain · doi:10.1016/j.pain.2013.06.004 · Cited by 457
Daousi, C., MacFarlane, I. A., Woodward, A., Nurmikko, T. J., Bundred, P. E., & Benbow, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01271.x · Cited by 454
Neuropathic pain: a practical guide for the clinician
Gilron, I. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060146 · Cited by 450
Self-citationHypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401
Laurel Gorman, A., Elliott, K. J., & Inturrisi, C. E. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13391-2 · Cited by 398
Siddall, P. J., Cousins, M. J., Otte, A., Griesing, T., Chambers, R., & Murphy, T. K. (2006) · Neurology · doi:10.1212/01.wnl.0000244422.45278.ff · Cited by 398
Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trials
Lynch, M. E., & Campbell, F. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03970.x · Cited by 397
Central post-stroke pain — a controlled trial of amitriptyline and carbamazepine
Leijon, G., & Boivie, J. (1989) · Pain · doi:10.1016/0304-3959(89)90108-5 · Cited by 392
Venlafaxine versus imipramine in painful polyneuropathy: A randomized, controlled trial
Sindrup, S. H., Bach, F. W., Madsen, C., Gram, L. F., & Jensen, T. S. (2003) · Neurology · doi:10.1212/01.wnl.0000058749.49264.bd · Cited by 373
Rao, R. D., Michalak, J. C., Sloan, J. A., Loprinzi, C. L., Soori, G. S., Nikcevich, D. A., Warner, D. O., Novotny, P., Kutteh, L. A., Wong, G. Y., et al. (2007) · Cancer · doi:10.1002/cncr.23008 · Cited by 360
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Tesfaye, S., Wilhelm, S., Lledo, A., Schacht, A., Tölle, T., Bouhassira, D., Cruccu, G., Skljarevski, V., & Freynhagen, R. (2013) · Pain · doi:10.1016/j.pain.2013.05.043 · Cited by 311
Combination pharmacotherapy for the treatment of neuropathic pain in adults
Chaparro, L. E., Wiffen, P. J., Moore, R. A., & Gilron, I. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008943.pub2 · Cited by 310
Self-citationThe selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy
Sindrup, S. H., Bjerre, U., Dejgaard, A., Brøsen, K., Aaes-Jørgensen, T., & Gram, L. F. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.183 · Cited by 284
Botulinum toxin for diabetic neuropathic pain: A randomized double-blind crossover trial
Yuan, R. Y., Sheu, J. J., Yu, J. M., Chen, W. T., Tseng, I. J., Chang, H. H., & Hu, C. J. (2009) · Neurology · doi:10.1212/01.wnl.0000345968.05959.cf · Cited by 281
NEUROPATHIC PAIN: REDEFINITION AND A GRADING SYSTEM FOR CLINICAL AND RESEARCH PURPOSES
Ochoa, J. L. (2009) · Neurology · doi:10.1212/01.wnl.0000346325.50431.5f · Cited by 273
Duehmke, R. M., Hollingshead, J., & Cornblath, D. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003726.pub3 · Cited by 267
Daniell, H. W. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.08.005 · Cited by 263 · cited 1×
“Pain Res Manag Vol 19 No 6 November/December 2014 333 analgesia include opioid-induced hyperalgesia (73) and opioid-induced endocrinopathy (74,75).”
BackgroundWhen should clinical guidelines be updated?
Shekelle, P., Eccles, M. P., Grimshaw, J. M., & Woolf, S. H. (2001) · BMJ · doi:10.1136/bmj.323.7305.155 · Cited by 262
Schwartz, S., Etropolski, M., Shapiro, D. Y., Okamoto, A., Lange, R., Haeussler, J., & Rauschkolb, C. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.537589 · Cited by 262
Topical capsaicin (high concentration) for chronic neuropathic pain in adults
Derry, S., Rice, A. S. C., Cole, P., Tan, T., & Moore, R. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007393.pub3 · Cited by 247
Combination pharmacotherapy for management of chronic pain: from bench to bedside
Gilron, I., Jensen, T. S., & Dickenson, A. H. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70193-5 · Cited by 240
Self-citationVranken, J. H., Dijkgraaf, M. G. W., Kruis, M. R., van der Vegt, M. H., Hollmann, M. W., & Heesen, M. (2008) · Pain · doi:10.1016/j.pain.2007.06.033 · Cited by 230
Kahan, M., Mailis, A., Wilson, L., & Srivastava, A. (2011) · Europe PMC (PubMed Central) · Cited by 230
Tremont-Lukats, I. W., Challapalli, V., McNicol, E. D., Lau, J., & Carr, D. B. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000186348.86792.38 · Cited by 226
Rintala, D. H., Holmes, S. A., Courtade, D., Fiess, R. N., Tastard, L. V., & Loubser, P. G. (2007) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2007.07.038 · Cited by 208
Neuropathic pain. Redefinition and a grading system for clinical and research purposes.
Treede, R.-D., Jensen, T. S., Campbell, J. N., Cruccu, G., Dostrovsky, J. O., Griffin, J. W., Hansson, P., Hughes, R. A., Nurmikko, T. J., & Serra, J. (2008) · Cited by 199
Sadosky, A., McDermott, A. M., Brandenburg, N. A., & Strauss, M. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2007.00164.x · Cited by 197
A Systematic Review of Pharmacologic Treatments of Pain After Spinal Cord Injury
Teasell, R. W., Mehta, S., Aubut, J.-A. L., Foulon, B., Wolfe, D. L., Hsieh, J. T. C., Townson, A. F., & Short, C. (2010) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2010.01.022 · Cited by 184
Gabapentin and Venlafaxine for the Treatment of Painful Diabetic Neuropathy
Simpson, D. A. (2001) · Journal of Clinical Neuromuscular Disease · doi:10.1097/00131402-200112000-00002 · Cited by 182
Toth, C., Mawani, S., Brady, S., Chan, C., Liu, C., Mehina, E., Garven, A., Bestard, J., & Korngut, L. (2012) · Pain · doi:10.1016/j.pain.2012.06.024 · Cited by 174
Topical capsaicin (low concentration) for chronic neuropathic pain in adults
Derry, S., & Moore, R. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010111 · Cited by 173
Selective Serotonin Reuptake Inhibitors and CNS Drug Interactions: A Critical Review of the Evidence
Sproule, B. A., Naranjo, C. A., Bremner, K. E., & Hassan, P. C. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733060-00004 · Cited by 169
Baron, R., Freynhagen, R., Tölle, T. R., Cloutier, C., Leon, T., Murphy, K. T., & Phillips, K. (2010) · Pain · doi:10.1016/j.pain.2010.04.013 · Cited by 163
Lamotrigine for acute and chronic pain
Wiffen, P. J., Derry, S., & Moore, R. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006044.pub3 · Cited by 159
Morley, J. S., Bridson, J. D., Nash, T. P., Miles, J. B., White, S. J., & Makin, M. K. (2003) · Palliative Medicine · doi:10.1191/0269216303pm815oa · Cited by 157
Safety and efficacy of pregabalin in patients with central post-stroke pain
Kim, J. S., Bashford, G. M., Murphy, K. T., Martin, A. J., Dror, V., & Cheung, R. Y. (2011) · Pain · doi:10.1016/j.pain.2010.12.023 · Cited by 142
Opioids and Chronic Neuropathic Pain
Foley, K. M. (2003) · New England Journal of Medicine · doi:10.1056/nejme030014 · Cited by 139
Furlan, A. D., Chaparro, L. E., Irvin, E., & Mailis, A. (2011) · Pain Research and Management · doi:10.1155/2011/465281 · Cited by 138
Self-citationVranken, J. H., Hollmann, M. W., van der Vegt, M. H., Kruis, M. R., Heesen, M. A., Vos, K., Pijl, A. J., & Dijkgraaf, M. G. W. (2010) · Pain · doi:10.1016/j.pain.2010.09.005 · Cited by 138
Gordh, T., Stubhaug, A., Jensen, T., Arnér, S., Biber, B., Boivie, J., Mannheimer, C., Kalliomäki, J., & Kalso, E. (2008) · Pain · doi:10.1016/j.pain.2007.12.011 · Cited by 132
Medical management of trigeminal neuropathic pains
Zakrzewska, J. M. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656561003767449 · Cited by 131
Efficacy of gabapentin in treating chronic phantom limb and residual limb pain
Smith, D. G., Ehde, D. M., Hanley, M. A., Campbell, K. M., Jensen, M. P., Hoffman, A. J., Awan, A. B., Czerniecki, J. M., & Robinson, L. R. (2005) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2005.05.0082 · Cited by 130
Evidence‐based Guideline: Treatment of Painful Diabetic Neuropathy
Bril, V., England, J. D., Franklin, G. M., Bačkonja, M., Cohen, J., Toro, D. D., Feldman, E. L., Iverson, D. J., Perkins, B. A., Russell, J. W., et al. (2011) · PM&R · doi:10.1016/j.pmrj.2011.03.008 · Cited by 125
Pharmacokinetics and Tolerability of Lidocaine Patch 5% with Extended Dosing
Gammaitoni, A. R., & Davis, M. W. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a185 · Cited by 111
Diagnostic criteria : the statistical derivation of the four criterion factors
Harden, R. (2005) · Medical Entomology and Zoology · Cited by 108
Hall, G. C., Morant, S. V., Carroll, D., Gabriel, Z., & McQuay, H. J. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-28 · Cited by 107
Lacosamide for neuropathic pain and fibromyalgia in adults
Hearn, L., Derry, S., & Moore, R. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009318.pub2 · Cited by 95
Topical Amitriptyline Versus Lidocaine in the Treatment of Neuropathic Pain
Ho, K.-Y., Huh, B. K., White, W. D., Yeh, C.-C., & Miller, E. J. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e318156db26 · Cited by 93
Methadone in the Treatment of Neuropathic Pain
Gagnon, B., Al-Mahrezi, A. M., & Schreier, G. (2003) · Pain Research and Management · doi:10.1155/2003/236718 · Cited by 91
Burden of chemotherapy-induced neuropathy—a cross-sectional study
Kautio, A.-L., Haanpää, M. L., Kautiainen, H., Kalso, E. A., & Saarto, T. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-1043-2 · Cited by 89
Escitalopram in painful polyneuropathy: A randomized, placebo-controlled, cross-over trial
Otto, M., Bach, F. W., Jensen, T. S., Brøsen, K., & Sindrup, S. H. (2008) · Pain · doi:10.1016/j.pain.2008.04.012 · Cited by 87
Combination tramadol plus acetaminophen for postsurgical pain
Smith, A. B., Ravikumar, T. S., Kamin, M., Jordan, D. M., Xiang, J. X., & Rosenthal, N. R. (2004) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2003.12.038 · Cited by 69
Lamotrigine for acute and chronic pain
Wiffen, P. J., & Rees, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006044.pub2 · Cited by 69
Methadone in the Management of Intractable Neuropathic Noncancer Pain
Moulin, D. E., Palma, D., Watling, C., & Schulz, V. (2005) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100004236 · Cited by 68
Self-citationCheville, A. L., Sloan, J. A., Northfelt, D., Jillella, A. P., Wong, G. Y., Bearden, J. D., Liu, H., Schaefer, P., Marchello, B. T., Christensen, B. J., et al. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0542-x · Cited by 65
A Review of the Use of Methadone for the Treatment of Chronic Noncancer Pain
Lynch, M. E. (2005) · Pain Research and Management · doi:10.1155/2005/286713 · Cited by 65
Mailis, A., & Taenzer, P. (2012) · Pain Research and Management · doi:10.1155/2012/794325 · Cited by 57
Self-citationPregabalin in Patients With Inadequately Treated Painful Diabetic Peripheral Neuropathy
Raskin, P., Huffman, C., Toth, C. C., Asmus, M. J., Messig, M., Sanchez, R. J., & Pauer, L. (2013) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e31829ea1a1 · Cited by 52
Dworkin, R. H., Panarites, C. J., Armstrong, E. P., Malone, D. C., & Pham, S. V. (2012) · Pain · doi:10.1016/j.pain.2012.01.015 · Cited by 49
SIDDALL, P., COUSINS, M., Otte, A., Griesing, T. A., CHAMBERS, R., & MURPHY, T. (2006) · Ghent University Academic Bibliography (Ghent University) · Cited by 44
Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy
Dworkin, R. H., Turk, D. C., Basch, E., Berger, A. M., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Markman, J. D., et al. (2011) · Pain · doi:10.1016/j.pain.2011.02.026 · Cited by 42
Kruszewski, S. P., & Shane, J. (2007) · Neurology · doi:10.1212/01.wnl.0000269479.84817.0a · Cited by 41
Venlafaxine versus imipramine in painful polyneuropathy:A randomized controlled trial
Sindrup, S. H., Bach, F. W., Madsen, C., F., G., & Jensen, T. S. (2003) · Cited by 32
Lacosamide for neuropathic pain and fibromyalgia in adults
Moore, A., Derry, S., & Hearn, L. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009318 · Cited by 24
Schwartz, S. L., Etropolski, M. S., Shapiro, D. Y., et al. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.537589 · Cited by 24
Ashman, E. J., & Gronseth, G. (2012) · Neurology · doi:10.1212/wnl.0b013e31825dce83 · Cited by 18
Rowbotham, M. C., Goli, V., Kunz, N. R., & Lei, D. (2004) · Pain · doi:10.1016/j.pain.2004.11.021 · Cited by 15
Tramadol--a new oral analgesic.
(1995) · PubMed · Cited by 11
Botulinum Toxin for Diabetic Neuropathic Pain
Brett, A. S. (2009) · Journal watch · doi:10.1056/jw200905120000002 · Cited by 8
Topical amitriptyline versus lidocaine in the treatment of neuropathic pain
HO, K., Huh, B. K., White, W. D., Yeh, C. C., & Miller, E. J. H. (2007) · Regional Anesthesia & Pain Medicine · doi:10.1097/00115550-200709001-00021 · Cited by 8
Escitalopram in painful polyneuropathy: A randomized, placebo-controlled, cross-over trial
Abram, S. E. (2009) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(09)79236-8 · Cited by 6
Botulinum Toxin Type A Induces Direct Analgesic Effects in Chronic Neuropathic Pain
Abram, S. E. (2009) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(09)79178-8 · Cited by 5
Schwendimann, R. N. (2012) · Yearbook of Neurology and Neurosurgery · doi:10.1016/j.yneu.2012.04.052 · Cited by 2
Research works printed but not linked: 1
- [20]Cohen J Statistical Power Analysis for the Behavioural Sciences New York, San Francisco, London Academic Press 1988
Cited by
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
Colloca, L., Ludman, T., Bouhassira, D., Baron, R., Dickenson, A. H., Yarnitsky, D., Freeman, R., Truini, A., Attal, N., Finnerup, N. B., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.2 · Cited by 2,058
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Cannabis-based medicines for chronic neuropathic pain in adults
Mücke, M., Phillips, T., Radbruch, L., Petzke, F., & Häuser, W. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012182.pub2 · Cited by 571
Gabapentin for chronic neuropathic pain in adults
Wiffen, P. J., Derry, S., Bell, R. F., Rice, A. S., Tölle, T. R., Phillips, T., & Moore, R. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007938.pub4 · Cited by 561
Metadata
- Authors
- Moulin, D., Boulanger, A., Clark, A., Clarke, H., Dao, T., Finley, G., Furlan, A., Gilron, I., Gordon, A., Morley-Forster, P., Sessle, B., Squire, P., Stinson, J., Taenzer, P., Velly, A., Ware, M., Weinberg, E., & Williamson, O.
- Affiliations
- Victoria Hospital (CA)
- Corresponding author
- Moulin, DE
- Venue
- Pain Research and Management
- Publisher
- Wiley
- Published
- 2014-01
- Volume
- 19
- Issue
- 6
- Pages
- 328-335
- ISSN
- 1203-6765 (ISSN-L)
- 1918-1523
- PMC
- PMC4273712
- OpenAlex
- W2206489433
- Cited by
- 529
- References
- 97
- Citations by year
- 2026: 14 · 2025: 14 · 2024: 54 · 2023: 38 · 2022: 38 · 2021: 58 · 2020: 53 · 2019: 53 · 2018: 52 · 2017: 60 · 2016: 50 · 2015: 43
- FWCI
- 34.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pain Research and Management (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship@McGill (McGill) (submittedVersion, cc-by)
- eScholarship@McGill (McGill) (submittedVersion, other-oa)
- Funders
- Neuropathic Pain Special Interest Group of the CPS
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- neuropathic pain, pharmacological management, gabapentinoids, pregabalin, tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, tramadol, controlled-release opioids, cannabinoids, methadone, antiepileptic drugs, tapentadol, botulinum toxin, analgesic combination, stepwise treatment, analgesic efficacy and safety
- MeSH terms
- Analgesics, Canada, Humans, Neuralgia, Chronic Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.